BCBP vs HYNE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BCBP exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to confirm safety from distress. The stock trades at a significant premium to its Graham Number of $4.79, currently priced at $7.86, despite deteriorating fundamentals including negative earnings and revenue growth. Profitability metrics like ROE (0.86%) and ROA (0.08%) are extremely weak, while the dividend is unsustainable with a payout ratio exceeding 1000%. Although analysts recommend a 'buy' with a $9.50 target, the company's track record of earnings misses and declining performance raises serious concerns.
Hoyne Bancorp exhibits a severe valuation disconnect, with a current price of $16.09 vastly exceeding its Graham Number ($3.67) and Intrinsic Value ($0.21). While the Piotroski F-Score of 4/9 indicates stable financial health, the company's profitability is negligible, evidenced by an ROE of 0.19% and an astronomical P/E ratio of 536.33. Despite strong top-line revenue growth of 51.4%, this growth is not translating into meaningful earnings. The stock is trading at a significant premium to its fundamental value despite a bearish technical trend.
Compare Another Pair
Related Comparisons
BCBP vs HYNE: Head-to-Head Comparison
This page compares BCB Bancorp, Inc. (BCBP) and Hoyne Bancorp, Inc. (HYNE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.